Literature DB >> 32942293

Activation of proprotein convertase in the mouse habenula causes depressive-like behaviors through remodeling of extracellular matrix.

Hikaru Ito1,2, Kanako Nozaki1,3, Kenji Sakimura4, Manabu Abe4, Shigeto Yamawaki5, Hidenori Aizawa6.   

Abstract

The lateral habenula (LHb) attracts a growing interest as a regulator of monoaminergic activity which were frequently reported to be defective in depression. Here we found that chronic social defeat stress (CSDS) increased production of pro-inflammatory cytokines in LHb associated with mobilization of monocytes and remodeling of extracellular matrix by increased matrix metalloproteinase (MMP) activity. RNA-seq analysis identified proprotein convertase Pcsk5 as an upstream regulator of MMP activation, with upregulation in LHb neurons of mice with susceptibility to CSDS. PCSK5 facilitated motility of microglia in vitro by converting inactive pro-MMP14 and pro-MMP2 to their active forms, highlighting its role in mobilization of microglia and monocytes in neuroinflammation. Suppression of Pcsk5 expression via small interfering RNA (siRNA) ameliorated depressive-like behaviors and pathological mobilization of monocytes in mice with susceptibility to CSDS. PCSK5-MMPs signaling pathway could be a target for development of the antidepressants targeting the inflammatory response in specific brain regions implicated in depression.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32942293      PMCID: PMC7852607          DOI: 10.1038/s41386-020-00843-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  55 in total

Review 1.  Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal.

Authors:  Michael D Weber; Jonathan P Godbout; John F Sheridan
Journal:  Neuropsychopharmacology       Date:  2016-06-20       Impact factor: 7.853

Review 2.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

3.  Ketamine blocks bursting in the lateral habenula to rapidly relieve depression.

Authors:  Yan Yang; Yihui Cui; Kangning Sang; Yiyan Dong; Zheyi Ni; Shuangshuang Ma; Hailan Hu
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

4.  Glial dysfunction in the mouse habenula causes depressive-like behaviors and sleep disturbance.

Authors:  Wanpeng Cui; Hiroaki Mizukami; Michiko Yanagisawa; Tomomi Aida; Masatoshi Nomura; Yoshikazu Isomura; Ryoichi Takayanagi; Keiya Ozawa; Kohichi Tanaka; Hidenori Aizawa
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

5.  BOLD Responses to Negative Reward Prediction Errors in Human Habenula.

Authors:  Ramiro Salas; Philip Baldwin; Mariella de Biasi; P Read Montague
Journal:  Front Hum Neurosci       Date:  2010-05-11       Impact factor: 3.169

6.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

Review 7.  Cytokines: abnormalities in major depression and implications for pharmacological treatment.

Authors:  Sinead M O'Brien; Lucinda V Scott; Timothy G Dinan
Journal:  Hum Psychopharmacol       Date:  2004-08       Impact factor: 1.672

8.  Synaptic potentiation onto habenula neurons in the learned helplessness model of depression.

Authors:  Bo Li; Joaquin Piriz; Martine Mirrione; ChiHye Chung; Christophe D Proulx; Daniela Schulz; Fritz Henn; Roberto Malinow
Journal:  Nature       Date:  2011-02-24       Impact factor: 49.962

Review 9.  Hyperactivation of the habenula as a link between depression and sleep disturbance.

Authors:  Hidenori Aizawa; Wanpeng Cui; Kohichi Tanaka; Hitoshi Okamoto
Journal:  Front Hum Neurosci       Date:  2013-12-10       Impact factor: 3.169

10.  Disrupted habenula function in major depression.

Authors:  R P Lawson; C L Nord; B Seymour; D L Thomas; P Dayan; S Pilling; J P Roiser
Journal:  Mol Psychiatry       Date:  2016-05-31       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.